Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics

Quest Diagnostics
Posted on: 27 Sep 18

SECAUCUS, N.J. and WOBURN, Mass., Sept. 24, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE :DGX ), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic services.

About 10 percent of women of child-bearing age in the United States have difficulty getting or staying pregnant, according to the Centers for Disease Control and Prevention. Woburn, Mass-based ReproSource provides a range of advanced diagnostic services, such as genetics-based ovarian health and recurrent pregnancy loss assessments, to help patients identify and surmount obstacles to fertility and pregnancy.

"Our acquisition of ReproSource delivers on our accelerate growth strategy, particularly in advanced diagnostics, and our goal to deliver the broadest access to diagnostic innovation," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "ReproSource is recognized for evidence-based expertise in reproductive diagnostics and will extend our breadth of services for providers and their patients."

Quest plans to offer ReproSource's services nationally as part of its comprehensive women's health and reproductive offerings for obstetricians, gynecologists, fertility specialists and other physicians.

Quest is a leader in advanced diagnostics services that help guide women and their physicians through the reproductive journey. These services include the company's proprietary QNatal™ noninvasive prenatal and QHerit™ carrier genetic screening services.

Additional terms were not disclosed.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 27/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.